Generative AI (GenAI) adds yet another disruptive force for business along with the COVID-19 pandemic, supply chain disruptions, workplace upheavals, talent shortages, inflation and rising interest rates. The good news is that off-the-shelf software interfaces of GenAI are so readily available it is almost equivalent to software as a service (SaaS). GenAI is accelerating change faster than any predecessor technology. Yet, many questions remain about its trustworthiness. What is the board’s role in balancing the opportunities and risks of GenAI and guiding organizations as the technology proliferates? 

This issue of Board Perspectives poses nine questions directors should consider when engaging CEOs and their teams in strategic conversations regarding GenAI.